Wakabayashi Jun, Hamaguchi Takahiro, Morifuji Masashi, Nagata Masashi
Wellness Science Labs, Meiji Holdings Co., Ltd, 1-29-1 Nanakuni, Hachioji, Tokyo, 192-0919, Japan.
Biogerontology. 2024 Dec 4;26(1):18. doi: 10.1007/s10522-024-10162-2.
Dry mouth results from decreased saliva secretion due to aging or drug side effects. Decreased saliva secretion causes dryness in the oral cavity that makes swallowing difficult and increases the risk of aspiration pneumonia. There are few fundamental treatments for dry mouth. Here we investigated whether treatment of old mice with nicotinamide mononucleotide (NMN) improved factors associated with dry mouth. Young (16-week-old) and old (113-week-old) male mice were treated subcutaneously with saline or NMN (300 mg/kg) once every two days for four weeks and saliva secretion was measured. The amount of nicotinamide adenine dinucleotide (NAD) in salivary gland tissues was measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Gene expression in the intestinal tract and salivary glands was measured by real-time PCR. The population of cells with acetylation in the submandibular gland was quantified by immunohistological staining. SA-β-gal activity in the submandibular gland was measured to assess cell senescence. Statistical analysis was performed by one-way analysis of variance with Tukey post hoc analysis. The submandibular glands from old mice treated with NMN exhibited increased saliva secretion and NAD levels, which both decrease with aging. In addition, the submandibular glands from NMN-treated old mice had decreased acetylation, numbers of senescent cells, and levels of senescence-associated secretory phenotype (SASP) factors, which all increase with aging, as well as increased aquaporin5 (AQP5) mRNA expression. NMN administration may improve dry mouth by regulating cellular senescence in the submandibular gland and increasing expression of AQP5, a water channel involved in saliva secretion, to inhibit age-related decreases in saliva secretion. It is necessary to elucidate further mechanism and confirm its effectiveness in humans.
口干是由于衰老或药物副作用导致唾液分泌减少所致。唾液分泌减少会导致口腔干燥,使吞咽困难,并增加吸入性肺炎的风险。目前针对口干几乎没有根本性的治疗方法。在此,我们研究了用烟酰胺单核苷酸(NMN)治疗老年小鼠是否能改善与口干相关的因素。将年轻(16周龄)和老年(113周龄)雄性小鼠每隔一天皮下注射生理盐水或NMN(300mg/kg),持续四周,然后测量唾液分泌量。通过液相色谱 - 串联质谱法(LC-MS/MS)测量唾液腺组织中烟酰胺腺嘌呤二核苷酸(NAD)的含量。通过实时PCR测量肠道和唾液腺中的基因表达。通过免疫组织化学染色对下颌下腺中乙酰化细胞的数量进行定量。测量下颌下腺中的SA-β-半乳糖苷酶活性以评估细胞衰老。采用单因素方差分析和Tukey事后分析进行统计分析。用NMN治疗的老年小鼠的下颌下腺显示唾液分泌增加,NAD水平升高,而这两者都会随着衰老而降低。此外,用NMN治疗的老年小鼠的下颌下腺乙酰化减少,衰老细胞数量减少,衰老相关分泌表型(SASP)因子水平降低,这些都会随着衰老而增加,同时水通道蛋白5(AQP5)mRNA表达增加。给予NMN可能通过调节下颌下腺中的细胞衰老并增加参与唾液分泌的水通道AQP5的表达,来抑制与年龄相关的唾液分泌减少,从而改善口干。有必要进一步阐明其机制并在人体中证实其有效性。